Extended Data Table 3:
Critical human ACE2-binding residues in SARS-CoV-2 and SARS-CoV RBDs.
Viral RBD | Year | 442 | 468-471 | 472 | 479 | 480 | 487 |
---|---|---|---|---|---|---|---|
SARS-human | 2002 | Y | P-PA | L | N | D | T |
SARS-civet | 2002 | Y | P-PA | L | K | D | S |
CoV-pangolin/GD | 2020 | L (455) | GVEG (482-485) | F(486) | Q (493) | S (494) | N (501) |
CoV-pangolin/GX | 2020 | L (455) | GQVG (482-485) | L (486) | E (493) | R (494) | T (501) |
Rs3367-bat | 2013 | S (443) | P-PA (469-472) | F (473) | N (480) | D (481) | N (488) |
RaTG13-bat | 2020 | L (455) | GQTG (482-485) | L (486) | Y (493) | R (494) | D (501) |
SARS-CoV-2 | 2019 | L (455) | GVEG (482-485) | F (486) | Q (493) | S (494) | N (501) |